Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jared A Leff

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Journal of Hospital Medicine|August 31, 2010
Comparing academic and community-based hospitalistsDavid Malkenson, Eric M Siegal, Jared A Leff, et al.
Journal of General Internal Medicine|January 5, 2012
Cost-effectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary careBruce R Schackman, Jared A Leff, Daniel Polsky, et al.
Journal of Substance Abuse Treatment|July 23, 2017
Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured populationJake R Morgan, Bruce R Schackman, Jared A Leff, et al.
Journal of Substance Abuse Treatment|August 30, 2017
Monetary conversion factors for economic evaluations of substance use disordersKathryn McCollister, Xuan Yang, Bisma Sayed, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 10, 2021
Economic Evaluations of Pharmacologic Treatment for Opioid Use Disorder: A Systematic Literature ReviewErica N Onuoha, Jared A Leff, Bruce R Schackman, et al.
Substance Abuse|March 21, 2018
Implementation of a nationwide health economic consultation service to assist substance use researchers: Lessons learnedSean M Murphy, Jared A Leff, Benjamin P Linas, et al.
Open Forum Infectious Diseases|December 13, 2017
Cost-Effectiveness Analysis of Probiotic Use to Prevent <i>Clostridium difficile</i> Infection in Hospitalized Adults Receiving AntibioticsNicole T Shen, Jared A Leff, Yecheskel Schneider, et al.
Transfusion|November 21, 2013
Cost-effectiveness of blood donor screening for Babesia microti in endemic regions of the United StatesMatthew S Simon, Jared A Leff, Ankur Pandya, et al.
Drug and Alcohol Dependence Reports|January 16, 2023
Cost of providing co-located hepatitis C treatment at a syringe service program exceeds potential reimbursement: Results from a clinical trialShashi N Kapadia, Benjamin J Eckhardt, Jared A Leff, et al.
Plos One|May 21, 2014
The hepatitis C cascade of care: identifying priorities to improve clinical outcomesBenjamin P Linas, Devra M Barter, Jared A Leff, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Journal of Hospital Medicine|August 31, 2010
Comparing academic and community-based hospitalistsDavid Malkenson, Eric M Siegal, Jared A Leff, et al.
Journal of General Internal Medicine|January 5, 2012
Cost-effectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary careBruce R Schackman, Jared A Leff, Daniel Polsky, et al.
Journal of Substance Abuse Treatment|July 23, 2017
Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured populationJake R Morgan, Bruce R Schackman, Jared A Leff, et al.
Journal of Substance Abuse Treatment|August 30, 2017
Monetary conversion factors for economic evaluations of substance use disordersKathryn McCollister, Xuan Yang, Bisma Sayed, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 10, 2021
Economic Evaluations of Pharmacologic Treatment for Opioid Use Disorder: A Systematic Literature ReviewErica N Onuoha, Jared A Leff, Bruce R Schackman, et al.
Substance Abuse|March 21, 2018
Implementation of a nationwide health economic consultation service to assist substance use researchers: Lessons learnedSean M Murphy, Jared A Leff, Benjamin P Linas, et al.
Open Forum Infectious Diseases|December 13, 2017
Cost-Effectiveness Analysis of Probiotic Use to Prevent <i>Clostridium difficile</i> Infection in Hospitalized Adults Receiving AntibioticsNicole T Shen, Jared A Leff, Yecheskel Schneider, et al.
Transfusion|November 21, 2013
Cost-effectiveness of blood donor screening for Babesia microti in endemic regions of the United StatesMatthew S Simon, Jared A Leff, Ankur Pandya, et al.
Drug and Alcohol Dependence Reports|January 16, 2023
Cost of providing co-located hepatitis C treatment at a syringe service program exceeds potential reimbursement: Results from a clinical trialShashi N Kapadia, Benjamin J Eckhardt, Jared A Leff, et al.
Plos One|May 21, 2014
The hepatitis C cascade of care: identifying priorities to improve clinical outcomesBenjamin P Linas, Devra M Barter, Jared A Leff, et al.
Pageof 4